PNC Financial Services Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53K Buy
1,465
+57
+4% +$1.95K ﹤0.01% 3312
2026
Q1
$46.6K Buy
1,408
+418
+42% +$17.7K ﹤0.01% 3253
2025
Q4
$45.8K Buy
990
+201
+25% +$8.41K ﹤0.01% 3258
2025
Q3
$27.6K Buy
789
+89
+13% +$3.09K ﹤0.01% 3505
2025
Q2
$20.7K Buy
700
+21
+3% +$599 ﹤0.01% 3555
2025
Q1
$20.3K Buy
679
+104
+18% +$3.18K ﹤0.01% 3532
2024
Q4
$16.5K Sell
575
-337
-37% -$11.2K ﹤0.01% 3619
2024
Q3
$35.2K Buy
912
+393
+76% +$14K ﹤0.01% 3258
2024
Q2
$16.7K Buy
519
+4
+0.8% +$139 ﹤0.01% 3564
2024
Q1
$20K Buy
515
+57
+12% +$1.99K ﹤0.01% 3447
2023
Q4
$14.1K Sell
458
-123
-21% -$3.08K ﹤0.01% 3604
2023
Q3
$13K Buy
581
+5
+0.9% +$114 ﹤0.01% 3641
2023
Q2
$12.4K Sell
576
-3
-0.5% -$68 ﹤0.01% 3780
2023
Q1
$13.9K Buy
579
+21
+4% +$557 ﹤0.01% 3655
2022
Q4
$12.9K Sell
558
-21
-4% -$423 ﹤0.01% 3666
2022
Q3
$9K Buy
579
+113
+24% +$1.99K ﹤0.01% 3801
2022
Q2
$9K Sell
466
-1,758
-79% -$29.6K ﹤0.01% 3836
2022
Q1
$44K Buy
2,224
+1,558
+234% +$29.4K ﹤0.01% 3180
2021
Q4
$13K Buy
666
+337
+102% +$6.57K ﹤0.01% 3701
2021
Q3
$6K Sell
329
-937
-74% -$20.3K ﹤0.01% 3872
2021
Q2
$30K Buy
1,266
+900
+246% +$20.8K ﹤0.01% 3309
2021
Q1
$8K Buy
+366
New +$8.7K ﹤0.01% 3700

Other funds holding COLL

PNC Financial Services Group's COLL Position: Q2 2026 in Review

PNC Financial Services Group increased its Collegium Pharmaceutical (COLL) stake by 4% in Q2 2026, buying an estimated $1.95K and bringing the position to 1,465 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

PNC Financial Services Group first reported a position in COLL in Q1 2021 and has held it in 22 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • PNC Financial Services Group held 1,465 shares of Collegium Pharmaceutical worth $53K as of Q2 2026.
  • PNC Financial Services Group bought 57 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.95K.
  • Collegium Pharmaceutical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3312 holding.
  • PNC Financial Services Group first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.